Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
[Feature articles]“Clinical application of DDS in cancer chemotherapy” Editor:Tetsuya Hamaguchi
Clinical development of the novel micellar compound in oncology area
Atsushi Osada
Author information
JOURNAL FREE ACCESS

2017 Volume 32 Issue 2 Pages 143-148

Details
Abstract

Drug Delivery System (DDS) has been utilized in drug development since before and the various DDS compounds were developed in a variety of therapeutic areas. So far three Antibody-Drug Conjugate (ADC) compounds were launched in oncology field and a lot of new ADC compounds are under developing. Also novel DDS compounds applied by the state-of-the-art technology are being investigated globally, therefore the development competition would be continuing. NanoCarrier Co., Ltd. researches and develops new anticancer drugs utilizing the micellar nanoparticles technology. Three compounds are in clinical phase. In this article the characteristics of clinical development of the novel micellar compounds would be summarized based on my experiences.

Content from these authors
© 2017 The Japan Society of Drug Delivery System
Previous article Next article
feedback
Top